-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Navidea Biopharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q1 2023.
- Navidea Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $19.7K, a 89.4% decline year-over-year.
- Navidea Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $136K, a 74.5% decline year-over-year.
- Navidea Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $301K, a 36.1% decline from 2021.
- Navidea Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $471K, a 104% increase from 2020.
- Navidea Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $231K, a 0.43% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)